| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |